[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"seronegative-antiphospholipid-syndrome\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:seronegative-antiphospholipid-syndrome":37},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":10,"sex":14,"minAge":15,"maxAge":16,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":26,"lastUpdatePostDateStruct":27,"startDateStruct":30,"completionDateStruct":32,"leadSponsor":34,"locationsCount":5},"100544754",false,"NCT06373003","Negative Antiphospholipid Syndrome: a Multicentric Study","INCLUSION CRITERIA:\n\n1. Group 1 \\[APS\\]: Patients fulfilling the classification criteria for antiphospholipid syndrome (seropositive APS, SP-APS)\n2. Group 2 \\[SN-APS\\]: patients with seronegative APS (SN-APS): with clinical criteria (thrombotic or obstetric) for APS, persistently negative for aPL, and with clinical features highly suggestive of APS (recurrent events, thrombotic + obstetrical events, extra-criteria manifestations, other autoimmune diseases)\n3. Group 3: patients with clinical criteria (thrombotic or obstetric) for APS, negative for aPL, but without clinical features highly suggestive of APS (recurrent events, thrombotic + obstetrical events, extra-criteria manifestations, other autoimmune diseases).\n4. Age \\\u003C 65 years (at event time)\n5. Less than 5 years from the first even\n\nEXCLUSION CRITERIA\n\n1. Group 2 and 3: patients with a known cause of thrombosis or obstetrical manifestations\n2. Deceased patients\n3. Less than 5 years from the first event","ALL","18 Years","65 Years",{"count":18,"type":19},105,"ESTIMATED","OBSERVATIONAL","Multicentre no-profit, national, (cross-sectional diagnostic) retrospective study, promoted by the Italian Society for Rheumatology.\n\nThe main objective of the study is to assess the diagnostic accuracy of non-criteria aPL (anti-vimentin\u002Fcardiolipin and anti-phosphatidylserine\u002Fprothrombin) in identifying APS in patients with thrombosis\u002Frecurrent adverse pregnancy outcomes.",[23,24],"Antiphospholipid Syndrome","Seronegative Antiphospholipid Syndrome","RECRUITING","2025-05-09",{"date":28,"type":29},"2025-05-14","ACTUAL",{"date":31,"type":29},"2024-09-21",{"date":33,"type":19},"2026-09",{"name":35,"class":36},"Italian Society for Rheumatology","OTHER",""]